Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in Princeton, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
107
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Y-Mabs Therapeutics Inc market cap is $391.22M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Y-Mabs Therapeutics Inc 52 week high is $16.11 as of November 20, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Y-Mabs Therapeutics Inc 52 week low is $3.55 as of November 20, 2026.
Y-Mabs Therapeutics Inc stock price today is $8.61.
Y-Mabs Therapeutics Inc stock price yesterday was $8.59.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Y-Mabs Therapeutics Inc's P/E ratio is -17.4.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Y-Mabs Therapeutics Inc P/B ratio is 4.4715.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Y-Mabs Therapeutics Inc 50-day moving average is $7.53.